Evaluating a New Mental Health Group for Asians and Asian Americans
Launched by STANFORD UNIVERSITY · Dec 15, 2023
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to evaluate a new mental health support group designed specifically for Asian and Asian American adults. Over 12 weeks, participants will be part of a group that focuses on learning about mental health issues within the Asian community while also helping members connect with each other. Researchers believe that by the end of the program, participants will feel less anxious or depressed and more socially connected than they did at the beginning.
To be eligible for the trial, participants must be at least 18 years old and identify as Asian or Asian American. It's important that they can understand and communicate in English, as the group sessions will be conducted in English. Unfortunately, individuals who are at high risk for suicide or who cannot give their consent for participation will not be able to join. If you're interested, please note that the trial is not yet recruiting participants, so keep an eye out for updates!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and older
- • Participants must identify as Asian or Asian American
- • Sufficient English proficiency to participate in a psychotherapy group conducted in English
- Exclusion Criteria:
- • Unable to provide written informed consent
- • Elevated suicide risk (e.g. recent active suicidal ideation, past-year suicide attempt) without a current individual mental health provider
- • Any other challenges that would preclude participation in group psychotherapy
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Lisa Zhang, PhD
Principal Investigator
Stanford University
Melanie Hom, PhD
Principal Investigator
Stanford University
Stacy Lin, PhD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported